• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Replies
3
Views
392
Replies
14
Views
13K
Replies
198
Views
9K
Replies
4
Views
319
Replies
32
Views
13K
Replies
872
Views
222K
Replies
742
Views
131K